Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 28.11% Profit Margin

May 03, 2023
QuantWave, a leading automated forecasting platform, successfully predicted a long trading opportunity for ELI LILLY AND COMPANY stock on February 6th, with a price target of $423.98. The forecast signal date indicated a price of $330.94, and on May 3rd, the stock reached the predicted target, resulting in a 28.11% profit margin for investors.

The achievement of this price target forecast showcases the accuracy and effectiveness of QuantWave's analytics in guiding investors towards profitable trading decisions. With detailed market analysis and precise predictions, QuantWave offers users the opportunity to capitalize on market movements and generate significant returns on investment.

ELI LILLY AND COMPANY's stock movement may have been influenced by various factors, including positive developments in the pharmaceutical industry, company-specific news, and overall market trends. QuantWave's advanced algorithms and forecasting models analyze these factors to provide actionable insights and profitable trading opportunities.

QuantWave's success in forecasting ELI LILLY AND COMPANY's stock price movement highlights the platform's capability to deliver valuable predictions for a wide range of stocks. Investors can leverage QuantWave's automated forecasting system to make informed trading decisions and maximize their investment returns.

For investors looking to enhance their trading strategies and delve deeper into QuantWave's forecasting system, QuantSchool offers comprehensive educational resources. QuantSchool equips users with the key principles and professional investment frameworks necessary to leverage the QuantWave platform effectively and generate consistent income from their investments.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

LLYFebruary 25, 2025Major Stock Movement: Lilly to participate in TD Cowens 45th Annual Health Care Conference  ~2 min.

Eli Lilly and Company (LLY) has recently caught the attention of investors as it prepares to participate in the TD Cowens 45th Annual Health Care Conference....

BMYFebruary 14, 2025QuantWave Successfully Predicts 8.86% Profit in Bristol-Myers Squibb Company Stock  ~2 min.

QuantWave, an automated forecasting platform, has once again demonstrated its prowess in predicting stock movements with the successful achievement of a price target forecast for Bristol-Myers Squibb Company. The forecast, which signaled a short direction on January 23, 2025, when the stock was priced at 57.74 USD, saw the target price of 52.63 USD reached on February 14, 2025, resulting in a prof...

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Target with Profit of 15.56%  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave on April 4, 2025....

REGNApril 10, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 17.79% Profit: QuantWave's Success  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave, resulting in a profit of 17.79%....

VRTXMarch 17, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits Forecast Price Target with a Profit of 9.49%  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has successfully reached the forecast price target set by QuantWave on December 17, 2024. The forecast signal indicated a "long" direction with a price of $469....

VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Stock Reaches Price Target Forecast with 8.02% Profit  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED stock successfully reached the price target forecast set by QuantWave on July 9, 2025....